All News

The FDA’s recent approval of Opdivo plus chemotherapy may be beneficial for some patients with non-small cell lung cancer, further highlighting the need for multidisciplinary care.

After surviving cancer, I’ve developed complex post-traumatic stress disorder, which comes with feelings of insecurity and anger.

Anti-TIGIT immunotherapy drugs may improve quality of life and survival, while being well tolerated by patients.

In recent years, BCMA-targeted therapies have changed the landscape of relapsed/refractory myeloma treatment, filling a previously unmet need.

The FDA’s partial hold means that no new patients with either leukemia or lymphoma can be enrolled onto the trial.

Anemia and anticoagulant use were both associated with higher blood loss and drainage volume, which may prolong a hospital stay after breast reconstruction surgery, according to recent study results.

As I prepared for my friend’s celebration of life, I reflected on other loved ones I lost to cancer and pondered why I am lucky enough to survive.

The KRAS G12C gene mutation in non-small cell lung cancer has been deemed “undruggable,” but recent effective therapies have successfully targeted this mutation, leading to shrinking of tumors and longer survival.

Regardless of whether it was guided by minimal residual disease status or given at a fixed dosage, consolidation Venclexta proved to be beneficial in patients with chronic lymphocytic leukemia.

As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, director of external affairs at Cancer Hope Network, about the importance of support following a lung cancer diagnosis.

As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, director of external affairs at Cancer Hope Network, about the psychosocial effects of a lung cancer diagnosis.

As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, director of external affairs at Cancer Hope Network, about support for caregivers of patients with lung cancer.

As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, from Cancer Hope Network, about seeking support for patients who may be nearing end of life, as well as support for family and friends after a loved one has passed.

“It’s important for patients to be educated on (next-generation sequencing), because the more we know about a patient’s cancer, the better we can design a personalized treatment plan,” says an expert.

While wandering around an outdoor art exhibit, I found a sculpture that really spoke to my cancer experience.

The results, according to the study authors, may highlight a bigger issue related to structural racism in health care.

Patients with stage 3 colon cancer who consume processed meat or unprocessed red meat after receiving their diagnosis may not be at an increased risk for cancer recurrence or death.

When my late wife was diagnosed with BRCA2-related triple-negative breast cancer, I realized how important medical literacy is for patients and their loved ones.

Watch Kristie L. Kahl, with Sham Mailankody, MBBS; Cesar Rodriguez, MD; and Lynn Steele, discuss new therapies on the horizon, during the CURE Educated Patient Multiple Myeloma Summit.

Here are some key takeaways from the CURE® Educated Patient® Multiple Myeloma Summit.

After surviving cancer and the many bad days that come with a diagnosis, voice actor Rob Paulsen noted that he had a newfound sense of empathy that helped him out of some of his darkest days.

As a melanoma advocate, I realized that people of color often are not included in research or properly understand their risks for skin cancer. Here’s what I’m doing to change that.

From liver cancer survivor planning to run the upcoming Boston Marathon with his organ donor to a common HIV drug showing promise in treating colorectal cancer, here’s what’s happening in the cancer space this week.

Watch Dr. Cesar Rodriguez, of the Multiple Myeloma Program at the Ichan School of Medicine at Mount Sinai, discuss upcoming FDA approvals in the space, during the CURE Educated Patient Multiple Myeloma Summit.

A phase 2 trial will investigate LTX-315 in patients with basal cell carcinoma, the most common form of skin cancer.

The presence of cancer in the lymph nodes may not be the strongest indicator of the need for adjuvant chemotherapy in older women with breast cancer, according to recent study results.

I have a lipoma on my back, and since I’m worried about both the aesthetics and potential malignancy of the fatty tumor, I’ve decided to have it removed.

The first patient was dosed in an early-phase trial evaluating the investigational cell therapy DeTIL-0255 for the treatment of advanced ovarian, cervical and endometrial cancer.

Watch Dr. Sham Mailankody, from Memorial Sloan Kettering Cancer Center, discuss CAR and BiTE therapy, during the CURE Educated Patient Multiple Myeloma Summit.

Researchers have treated the first patient in the PRECISION 1 trial with Fyarro to assess the drug’s efficacy across several endpoints including survival among more than 100 patients with solid tumors that exhibit certain genetic alterations.